Maximus Tirzepatide Review: Cost, Coverage & Honest Verdict (2026)

Maximus is an established men's-health platform whose core product is testosterone therapy, with compounded tirzepatide and longevity treatments alongside. Its coverage is the widest in this category — all 50 states plus DC — and pricing is genuinely flat across dose tiers, so titration doesn't raise the bill. Third-party reviewers report an F rating at the BBB, with complaints about prescriptions that were never filled — worth reading before you commit. Every fact here comes from the company's own published program.

What Maximus is

Maximus (maximustribe.com) is a men's-health platform whose core business is testosterone therapy, with compounded GLP-1s and longevity treatments offered alongside. Coverage is in all 50 states plus DC — the broadest footprint in this category — and it runs a defined microdose protocol for people with less weight to lose, a more coherent offer than most microdose marketing in this space.

What Maximus costs in 2026

Compounded tirzepatide is priced $359.99/month month-to-month, flat across all dose tiers, falling to $299/month on a four-month plan and $240/month on a twelve-month plan — both figures on Maximus' own site. A separate microdose protocol is quoted from roughly $198/month. Brand Zepbound is listed from $449.99/month, with brand Mounjaro from $1,249.99/month.

The BBB record worth reading before you commit

Third-party reviewers report an F rating at the Better Business Bureau, with complaints specifically about prescriptions that were never fulfilled. This review's live pass could not independently pull the current BBB rating directly, but it's a specific, checkable claim worth verifying yourself at bbb.org before starting an intake — the reason this provider ranks lower on trust despite competitive pricing and broad coverage.

The brand-vs-compounded question

Maximus dispenses compounded tirzepatide, not the FDA-approved branded product by default, though brand Zepbound and Mounjaro are listed as separate options. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Maximus' real strengths: the broadest coverage in this category (all 50 states plus DC), flat pricing across every dose tier, a defined microdose protocol, and an established brand with real operating history — unusual among compounded GLP-1 sellers. The trade-offs: no LegitScript or PCAB certification was found, and third-party reviewers report an F BBB rating with unfulfilled-prescription complaints. At $359.99/month month-to-month, it's among the more expensive compounded options in this category, with the $240 rate requiring a full year's commitment. GLP-1 is also a secondary line here — testosterone therapy is the core business. As with any GLP-1 program, check the BBB record yourself before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Maximus offers the broadest coverage and genuinely flat pricing in this category, but the reported F BBB rating and unfulfilled-prescription complaints are worth checking yourself before you commit — verify the current BBB record directly at bbb.org. If a cleaner trust record matters more than the widest coverage, compare it against ShedRx or bmiMD. See our best tirzepatide providers ranking for the full field.